English
简体中文
Total: £ 56.28
2025-12-04 | Pages: 110 | Tables: 110
The global market for Olopatadine was valued at US$ 627 million in the year 2024 and is projected to reach a revised size of US$ 835 million by 2031, growing at a CAGR of 4.3% during the forecast period.The 2025 U.S. tariff policies introduce profoun...
2025-12-04 | Pages: 83 | Tables: 82
The global market for Stress Dietary Supplements was valued at US$ 870 million in the year 2024 and is projected to reach a revised size of US$ 1615 million by 2031, growing at a CAGR of 10.0% during the forecast period.Stress Dietary Supplements are...
2025-12-04 | Pages: 84 | Tables: 88
The global market for Sleep Disorders Dietary Supplements was valued at US$ 3833 million in the year 2024 and is projected to reach a revised size of US$ 6988 million by 2031, growing at a CAGR of 9.6% during the forecast period.Sleep Disorders Dieta...
2025-12-04 | Pages: 126 | Tables: 118
The global market for Liver Cleanse Supplement was valued at US$ 425 million in the year 2024 and is projected to reach a revised size of US$ 627 million by 2031, growing at a CAGR of 5.7% during the forecast period.The 2025 U.S. tariff policies intr...
2025-12-04 | Pages: 91 | Tables: 89
The global market for Growth Hormone Inhibiting Hormone Drug was valued at US$ 5315 million in the year 2024 and is projected to reach a revised size of US$ 12034 million by 2031, growing at a CAGR of 12.3% during the forecast period.The 2025 U.S. ta...
2025-12-03 | Pages: 82 | Tables: 87
The global market for Radiological Marker was valued at US$ 4438 million in the year 2024 and is projected to reach a revised size of US$ 7270 million by 2031, growing at a CAGR of 7.4% during the forecast period.Radiological Marker refers to a class...
2025-12-03 | Pages: 83 | Tables: 87
The global market for Diagnostic Imaging Marker was valued at US$ 1352 million in the year 2024 and is projected to reach a revised size of US$ 2172 million by 2031, growing at a CAGR of 7.0% during the forecast period.Diagnostic imaging markers are ...
2025-12-03 | Pages: 92 | Tables: 99
The global market for Organic Zinc Supplements was valued at US$ 1259 million in the year 2024 and is projected to reach a revised size of US$ 1825 million by 2031, growing at a CAGR of 5.6% during the forecast period.Organic zinc supplements are die...
2025-12-03 | Pages: 79 | Tables: 82
The global market for Levothyroxine Sodium Tablets Hormone Medication was valued at US$ 96 million in the year 2024 and is projected to reach a revised size of US$ 200 million by 2031, growing at a CAGR of 10.1% during the forecast period.The 2025 U....
2025-12-02 | Pages: 111 | Tables: 113
The global market for Hyaluronic Acid Injection Products was valued at US$ 9092 million in the year 2024 and is projected to reach a revised size of US$ 18351 million by 2031, growing at a CAGR of 10.3% during the forecast period.The 2025 U.S. tariff...
2025-12-02 | Pages: 92 | Tables: 93
The global market for Pharma Grade Lactose Excipients was valued at US$ 9585 million in the year 2024 and is projected to reach a revised size of US$ 14360 million by 2031, growing at a CAGR of 6.0% during the forecast period.The 2025 U.S. tariff pol...
2025-12-02 | Pages: 78 | Tables: 82
The global market for Bird's Nest Peptide was valued at US$ 3.86 million in the year 2024 and is projected to reach a revised size of US$ 15.27 million by 2031, growing at a CAGR of 21.7% during the forecast period.The 2025 U.S. tariff policies intro...
2025-12-02 | Pages: 135 | Tables: 145
The global market for Oral Sulfonylurea for Type 2 Diabetes was valued at US$ 22477 million in the year 2024 and is projected to reach a revised size of US$ 30470 million by 2031, growing at a CAGR of 4.4% during the forecast period.The 2025 U.S. tar...
2025-12-02 | Pages: 128 | Tables: 132
The global market for Sulfonylureas for Type 2 Diabetes was valued at US$ 25325 million in the year 2024 and is projected to reach a revised size of US$ 35391 million by 2031, growing at a CAGR of 4.9% during the forecast period.The 2025 U.S. tariff ...
2025-12-02 | Pages: 74 | Tables: 78
The global market for Chronic Sarcoidosis Therapeutic was valued at US$ 276 million in the year 2024 and is projected to reach a revised size of US$ 584 million by 2031, growing at a CAGR of 11.7% during the forecast period.Chronic Sarcoidosis Therap...
